The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaefer, G.
Right arrow Articles by Schindler, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaefer, G.
Right arrow Articles by Schindler, U.
The Journal of Immunology, 2001, 166: 5859-5863.
Copyright © 2001 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: FISP (IL-4-Induced Secreted Protein), a Novel Cytokine-Like Molecule Secreted by Th2 Cells1

Gabriele Schaefer, Chandrasekar Venkataraman2 and Ulrike Schindler

Tularik Inc., Two Corporate Drive, South San Francisco, CA 94080

Th cell subsets, namely Th1 and Th2 cells, play an important role in mounting an immune response against invading pathogens. Several genes are selectively up-regulated during differentiation and effector phases of Th subsets. In this study, we report the identification of a novel cytokine-like molecule designated FISP (IL-4-induced secreted protein), which is selectively expressed and secreted by Th2 cells. Detectable levels of FISP are observed only 3 days after initiation of Th2 differentiation. Expression of FISP in developing Th cells requires at least two signals: TCR signaling involving protein kinase C activation and STAT6-dependent IL-4R signaling.




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. Gao, X. Sun, X. Chen, Y. Wang, B. A. Foster, J. Subjeck, P. B. Fisher, and X.-Y. Wang
Secretable Chaperone Grp170 Enhances Therapeutic Activity of a Novel Tumor Suppressor, mda-7/IL-24
Cancer Res., May 15, 2008; 68(10): 3890 - 3898.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
N. W. Bartlett, L. Dumoutier, J.-C. Renauld, S. V. Kotenko, C. E. McVey, H.-J. Lee, and G. L. Smith
A new member of the interleukin 10-related cytokine family encoded by a poxvirus
J. Gen. Virol., June 1, 2004; 85(6): 1401 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. Asadullah, W. Sterry, and H. D. Volk
Interleukin-10 Therapy--Review of a New Approach
Pharmacol. Rev., June 1, 2003; 55(2): 241 - 269.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Ekmekcioglu, J. A. Ellerhorst, J. B. Mumm, M. Zheng, L. Broemeling, V. G. Prieto, A. L. Stewart, A. M. Mhashilkar, S. Chada, and E. A. Grimm
Negative Association of Melanoma Differentiation-associated Gene (mda-7) and Inducible Nitric Oxide Synthase (iNOS) in Human Melanoma: MDA-7 Regulates iNOS Expression in Melanoma Cells
Mol. Cancer Ther., January 1, 2003; 2(1): 9 - 17.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Vandenbroeck, I. Alloza, D. Brehmer, A. Billiau, P. Proost, N. McFerran, S. Rudiger, and B. Walker
The Conserved Helix C Region in the Superfamily of Interferon-gamma /Interleukin-10-related Cytokines Corresponds to a High-affinity Binding Site for the HSP70 Chaperone DnaK
J. Biol. Chem., July 5, 2002; 277(28): 25668 - 25676.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. G. Caudell, J. B. Mumm, N. Poindexter, S. Ekmekcioglu, A. M. Mhashilkar, X. H. Yang, M. W. Retter, P. Hill, S. Chada, and E. A. Grimm
The Protein Product of the Tumor Suppressor Gene, Melanoma Differentiation-Associated Gene 7, Exhibits Immunostimulatory Activity and Is Designated IL-24
J. Immunol., June 15, 2002; 168(12): 6041 - 6046.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Wolk, S. Kunz, K. Asadullah, and R. Sabat
Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members?
J. Immunol., June 1, 2002; 168(11): 5397 - 5402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Wang, Z. Tan, R. Zhang, S. V. Kotenko, and P. Liang
Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2
J. Biol. Chem., February 22, 2002; 277(9): 7341 - 7347.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. A. Ellerhorst, V. G. Prieto, S. Ekmekcioglu, L. Broemeling, S. Yekell, S. Chada, and E. A. Grimm
Loss of MDA-7 Expression With Progression of Melanoma
J. Clin. Oncol., February 15, 2002; 20(4): 1069 - 1074.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Dumoutier, C. Leemans, D. Lejeune, S. V. Kotenko, and J.-C. Renauld
Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types
J. Immunol., October 1, 2001; 167(7): 3545 - 3549.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.